Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 3/20 | 0.70 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.70 |
| ▸ | PDE4A | P27815 | 1/20 | 0.70 |
| ▸ | BLVRB | P30043 | 1/20 | 0.70 |
| ▸ | KDR | P35968 | 1/20 | 0.70 |
| ▸ | HTT | P42858 | 1/20 | 0.70 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.66 |
| ▸ | HPGD | P15428 | 4/20 | 0.66 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.66 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.66 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.66 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.61 |
| ▸ | APP | P05067 | 1/20 | 0.61 |
| ▸ | THRB | P10828 | 1/20 | 0.61 |
| ▸ | RECQL | P46063 | 1/20 | 0.61 |
| ▸ | BLM | P54132 | 1/20 | 0.61 |
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.59 |
| ▸ | TSHR | P16473 | 2/20 | 0.59 |
| ▸ | CA12 | O43570 | 1/20 | 0.59 |
| ▸ | CA1 | P00915 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1624756 | 1.00 | MEN1 (0.70) | MEN1KMT2APDE4ABLVRBKDR | |
| SCHEMBL26730466 | 1.00 | MEN1 (0.70) | MEN1KMT2APDE4ABLVRBKDR | |
| SCHEMBL10930328 | 0.98 | MEN1 (0.68) | MEN1KMT2APDE4ABLVRBKDR | |
| SCHEMBL1624852 | 0.92 | MEN1 (0.85) | MEN1KMT2APDE4ABLVRBKDR | |
| SCHEMBL3386039 | 0.92 | MEN1 (0.85) | MEN1KMT2APDE4ABLVRBKDR | |
| SCHEMBL10334178 | 0.91 | KMT2A (0.59) | MEN1KMT2APDE4ABLVRBKDR | |
| SCHEMBL10334179 | 0.91 | KMT2A (0.59) | MEN1KMT2APDE4ABLVRBKDR | |
| SCHEMBL3708516 | 0.88 | ALDH1A1 (0.56) | MEN1KMT2APDE4ABLVRBKDR | |
| SCHEMBL12374379 | 0.88 | ALDH1A1 (0.56) | MEN1KMT2APDE4ABLVRBKDR | |
| SCHEMBL24849465 | 0.85 | KMT2A (0.61) | MEN1KMT2APDE4ABLVRBKDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023104665-A1 | METAL ORGANIC FRAMEWORKS FOR THE SELECTIVE CAPTURE OF VOLATIL ORGANIC COMPOUNDS COMPRISING CARBOXYLIC ACID FUNCTIONAL GROUP(S) AND/OR VOLATILE ALCOHOLS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2023-06-15 | — | — | WO | claimed |
| EP-4194084-A1 | METAL ORGANIC FRAMEWORKS FOR THE SELECTIVE CAPTURE OF VOLATIL ORGANIC COMPOUNDS COMPRISING CARBOXYLIC ACID FUNCTIONAL GROUP(S) | Centre National de la Recherche Scientifique (FR) | 2023-06-14 | — | — | EP | claimed |
| EP-1663253-B1 | FORMULATIONS CONTAINING SALICYLATES AND THEIR USE FOR TREATING INFLAMMATORY BOWEL DISEASE | AGI THERAPEUTICS RES LTD (IE) | 2010-12-01 | — | — | EP | claimed |
| WO-2023104665-A1 | METAL ORGANIC FRAMEWORKS FOR THE SELECTIVE CAPTURE OF VOLATIL ORGANIC COMPOUNDS COMPRISING CARBOXYLIC ACID FUNCTIONAL GROUP(S) AND/OR VOLATILE ALCOHOLS | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2023-06-15 | — | — | WO | disclosed |
| EP-4194084-A1 | METAL ORGANIC FRAMEWORKS FOR THE SELECTIVE CAPTURE OF VOLATIL ORGANIC COMPOUNDS COMPRISING CARBOXYLIC ACID FUNCTIONAL GROUP(S) | Centre National de la Recherche Scientifique (FR) | 2023-06-14 | — | — | EP | disclosed |
| US-20180248131-A1 | ORGANIC COMPOUND, METHOD FOR PREPARING SAME, ORGANIC SEMICONDUCTOR MATERIAL CONTAINING SAME, AND ORGANIC TRANSISTOR CONTAINING SAME | DIC CORPORATION (JP) | 2018-08-30 | — | — | US | disclosed |
| EP-3342769-A1 | ORGANIC COMPOUND, METHOD FOR MANUFACTURING SAME, ORGANIC SEMICONDUCTOR MATERIAL CONTAINING SAME, AND ORGANIC TRANSISTOR CONTAINING SAME | DIC Corporation (JP) | 2018-07-04 | — | — | EP | disclosed |
| EP-0145776-A1 | A PHARMACEUTICAL COMPOSITION CONTAINING AZO-BIS-SALICYLIC ACID OR A SALT THEREOF AND A METHOD FOR TREATMENT OF INFLAMMATORY CONDITIONS IN THE INTESTINE | PHARMACIA AB (SE) | 1985-06-26 | — | — | EP | disclosed |
| WO-1985000012-A1 | A PHARMACEUTICAL COMPOSITION CONTAINING AZO-BIS-SALICYLIC ACID OR A SALT THEREOF AND A METHOD FOR TREATMENT OF INFLAMMATORY CONDITIONS IN THE INTESTINE | PHARMACIA AB (SE) | 1985-01-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180248131-A1 | ORGANIC COMPOUND, METHOD FOR PREPARING SAME, ORGANIC SEMICONDUCTOR MATERIAL CONTAINING SAME, AND ORGANIC TRANSISTOR CONTAINING SAME | TST, SOAT1, SOAT2 | MEN1 1120/4885KMT2A 1336/4885PDE4A 4469/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.